ASX:OILHealth Care Equipment & ServicesHealth Care Equipment
Optiscan Imaging Ltd
$0.170
$0.010 (5.56%)
Day Range
$0.155 – $0.180
52 Week Range
$0.078 – $0.200
Volume
429.94K
Avg Volume (10D)
299.76K
Market Cap
$177.51M
Price Chart
Market Statistics
Open$0.180
Previous Close$0.180
Day High$0.180
Day Low$0.155
52 Week High$0.200
52 Week Low$0.078
Valuation
Market Cap177.51M
Shares Outstanding1.04B
Price to Book8.77
Trading Activity
Volume429.94K
Value Traded72.67K
Bid$0.160 × 100,000
Ask$0.170 × 49,996
Performance
1 Day-5.13%
5 Day15.63%
13 Week76.19%
52 Week111.67%
YTD85.00%
Technical Indicators
RSI (14)56.50
50-Day SMA$0.146
200-Day SMA$0.113
Latest News
Biotechnology
Optiscan Imaging Advances Head and Neck Cancer Study Ahead of Schedule
Optiscan Imaging pushes Stage 2 of head and neck cancer live-imaging study ahead of schedule, accelerating clinical validation and potential FDA submissions.
Biotechnology
Optiscan Imaging Launches First Clinical Device into US Veterinary Market
Optiscan debuts InSpecta as its first US commercial clinical imaging device after FDA CVM submission, unlocking US sales in a $15.9B market.
Biotechnology
Optiscan Submits FDA Dossier for Inspecta Imaging Device Targeting Lucrative US Veterinary Market
Optiscan submits FDA dossier for InSpecta veterinary imaging, unlocking US$11.9B market with real-time, non-invasive imaging for pets.
Biotechnology
Optiscan Imaging Launches Head and Neck Cancer Study Using Invue and InForm Digital Pathology Tools
Optiscan Imaging (ASX: OIL) has partnered with Australian Clinical Labs to launch the nation’s first-in-human head and neck cancer imaging study utilising the InVue and InForm digital pathology devices.